 |
|
|
| Committees |
|
| Committee
Members |
| |
Organising
Committee |
|
|
| |
Douglas
Westerlund |
Uppsala
University |
Sweden
(Chairman) |
| |
Per
Andrén |
Uppsala
University |
Sweden |
| |
Margareta
Bielenstein |
AstraZeneca,
Södertälje |
Sweden |
| |
Sven
Jacobsson |
AstraZeneca,
Södertälje |
Sweden |
| |
Märit Johansson |
Swedish
Academy of Pharmaceutical Sciences, Stockholm |
Sweden |
| |
Karin Markides |
Uppsala
University |
Sweden |
| |
György
Marko-Varga |
AstraZeneca, Lund |
Sweden |
| |
Johan Roeraade |
Royal
Institute of Technology, Stockholm |
Sweden |
| |
|
|
|
| |
International
Scientific Committee |
|
| |
Heinz
Engelhardt* |
University
of Saarland, Saarbrücken |
Germany |
| |
Fritz
Erni* |
Novartis,
Basel |
Switzerland |
| |
John
Frenz* |
Genentech,
San Francisco |
USA |
| |
Georges
Guiochon* |
University
of Tennessee, Knoxville |
USA |
| |
William
Hancock* |
Barnett
Institute, Boston |
USA |
| |
Barry
Karger* |
Barnett
Institute, Boston |
USA |
| |
Bingcheng
Lin, |
Chinese
Academy of Science, Dalian |
China |
| |
Wolfgang
Lindner* |
University
of Vienna, Vienna |
Austria |
| |
Peter
Schoenmakers*, |
University
of Amsterdam |
The
Netherlands |
| |
Frantisek
Svec |
University
of California, Berkeley |
USA |
| |
Nobuo
Tanaka |
Kyoto Institute of Technology, Kyoto |
Japan |
| |
Douglas
Westerlund* |
Uppsala
University, Uppsala |
Sweden |
| |
Ed
Yeung*, |
Iowa
State University, Ames |
USA |
| |
|
|
|
| |
*
Permanent member |
|
|
|
|
|
|
|
|
|
 |
